BioLife Summits

We are excited to officially announce the second annual Texas BioLife Summit! We will be returning to Dallas for another day of captivating panel discussions and fantastic networking opportunities. Join 200+ local biotech executives for 10 hours of collaborating and sharing ideas on how to continue driving the industry in Texas. ▶ WHERE: The Hilton Anatole ▶ WHEN: February 27, 2025   We received incredible feedback at our first Dallas event this year and have been eagerly anticipating our return. We look forward to bringing together the biotech and life sciences community of Texas for a second year in a row, and want to see you there! Visit our website to see the full speaker lineup and register to attend: https://lnkd.in/ecdZs3KS

Novoron Bioscience prides itself on being part of the vibrant and innovative biotech and life science ecosystem in San Diego. We are firm believers in the power of collaboration, sharing ideas and working together to accelerate progress. Our CEO, Travis Stiles, loved taking part in a recent BioLife Summits panel discussion that helped foster these types of discussions. #biotech #biotechinnovation #lifesciences

✨ The BioLife Summit San Diego was a huge success, and Collaborative Clinical Research Consulting, Inc. (CCRC) is proud to have been part of this incredible event! It’s always exciting to come together with industry leaders, reconnect with old friends, and make new connections that shape the future of clinical research. 🌟 Thank you to everyone who made this summit a memorable experience — the energy, collaboration, and shared passion for advancing science were truly inspiring. Looking forward to the next one! #BioLifeSummit #ClinicalResearch #Networking #CCRC #Innovation #Collaboration BioLife Summits

🙌

That's a wrap on our 2024 Southern California BioLife Summit! We're incredibly grateful to those of you that joined us this Wednesday, September 18th in San Diego for a day full of exciting discussion and valuable networking opportunities. The day wouldn't have been possible without the support from each of our sponsors and attendees. We're not stopping here! We have a fantastic schedule of events lined up for 2025 so keep your eyes on our page as we continue announcing updates for everything upcoming.

The 2024 Southern California BioLife Summit continued on this afternoon with great questions and conversation!   Patrick McCarthy, Esq. (CEO) of Validcare gave us a great lead back into the day as he shared innovative ways that Validcare is reworking the CRO model to fit the needs of small biopharma, as working with a CRO should not be a 'one size fits all' approach.   This brought us straight into the next exciting discussion on 'Clinical Trial Development', moderated once again by Trinh Le (CEO & Founder) of Collaborative Clinical Research Consulting, Inc., Kim Potter (Director Clinical Operations) of Alume Biosciences, Gregory J Opiteck (Head of Precision & Translational Medicine) of Affini-T Therapeutics, and Jeena M. Thevathasan (Director Clinical Operations) of Mirati Therapeutics (a BMS company) joined Trinh in a thoughtful conversation about what to consider when moving from preclinical to clinical phases of development. This group brings together experiences from both large and small pharma, perfectly positioning them to discuss challenges the could be faced by many different companies and key strategies for navigating this transition.   After a quick afternoon break to enjoy the sunshine and snacks, the audience was welcomed back by the 'From Drug Discovery to Market in California' panelists. This discussion was led by Christopher Sauls (Director of Business Development) of Mix Talent, and included insights from Habib Torfi (CEO & Founder) of Invitrx Therapeutics, Michael Howell (CSO & Head of Translational Medicine) of Zura Bio Limited (Nasdaq: ZURA), and Xicheng Sun (Vice President) of Crestone Pharma. They covered how companies unique target can affect what the path to clinic looks like and what implications that could have on future collaborations. We would be remiss to not hit that AI buzzword here and examine the potential advantages and challenges of using AI in the drug discovery process.   We couldn't spend the whole day talking about the new and exciting ways we're out here trying to save lives and not dedicate some of that time to exploring the topic of 'Adapting Through the Evolution of Healthcare Relationships'. Moderated by Ronald Blum, Ph.D. (CSO) of Sinai Labs, Daniel de Moraes Branco (Director of Corporate Planning) of Artiva Biotherapeutics, and Paul D. Reay (Past Chairman & CEO) of Biological Dynamics took the stage to discuss the changing healthcare landscape. They examined the opportunities that exist for improving patient care and how companies can fill these gaps for our patients. What an inspiring conversation to wrap up the day!   We loved seeing the biotech community in San Diego come together to share experiences and advice, and build up their community while making new connections! Thank you for having us, San Diego! Until next time ☀️ #BiolifeSummits #California #Products #Biotech #Innovation #Ethics #FutureTrends #Investments #AI #DrugDiscovery #Pharma #Therapeutics

The San Diego BioLife Summit is here 🎉 What a morning we've had, full of insightful discussion, fantastic community building, and beautiful sunshine ☀️ The day kicked off with 'Commercializing New Products and Technology in Today's Market' moderated by Aryeh Goldberg (COO) of Bruin Biometrics, LLC. Panleists included Steven Rees, PhD (CEO & Founder) of Defined Bioscience, Walid Soussou (CEO & Founder) of Wearable Sensing, Don Lin (Chief Innovation Officer & Co-founder) of Telesair, Inc, and Jahnavi Lokre (COO) of Diality. They discussed barriers in the commercialization/market adoption process and how to better develop a future approach. Further discussion surrounded navigating times in which you may be faced with a decision to continue a product or to "cut your losses".   Next, Trinh Le (CEO & Founder) of Collaborative Clinical Research Consulting, Inc. moderated a stellar group of panelists on the 'Navigating the Life Sciences Investment Landscape' discussion, including: Camilla Gomiero Wade (VP Commercial Strategy & Business Development) of Engrail Therapeutics, Mehmet Sencan (COO) of Integrated Medical Sensors,Jill Jene (CBO) of Amber Ophthalmics, and Ajay Kshatriya (CEO) of Aizen Therapeutics. These seasoned biotech experts discussed all things funding from aligning strategic goals with potential investor interests, to M&A considerations and getting creative when the investment competition gets tough.   After a nice break for coffee, the 'Devices and Diagnostics: Where Health and Innovation Meet' panel took the stage with high energy! Our very own Brigid McGivern, SVP of BioLife Summits moderated an innovative group of panelists including Nils Olsson (VP of CMC) of Cerus, Rahaf Al Assil, MD MHSC (CEO & Founder) of PantridgeDTell, Mike Nerenberg (Chief Medical Officer) of Exagen Inc., and Kevin Harris (President) of CureMetrix. Our attendees got to learn about strategies for staying compliant with various regulatory bodies, answering the ethical questions surrounding medical device and diagnostic development, and future trends in this space.   Finally, we leapt into the 'Next Generation Life Science Leaders' panel, moderated by Derek C. Dashti, MS, PhD, MBA (CEO & Founder) of D&P Bioinnovations. Our panelists include Noah Davidsohn (CSO & Co-founder) of Rejuvenate Bio, Travis Stiles (CEO & CSO) of Novoron Bioscience, Natalise Kalea Robinson (CEO & Co-founder) of Parallel Health, Kurinji Pandiyan (VP Portfolio & Strategy) of Poseida Therapeutics, Inc., and Tobin Dickerson (CSO & Co-founder) of Mindera Health. They examined how today's leaders can help shape future regulations and policies, what role AI plays in today's decisions, strategies for patient equity and cost, and much more.   Our attendees are taking a quick break to reset and network. Keep checking our LinkedIn for more session updates and insights throughout the day! #BiolifeSummits #California #Products #Biotech #Innovation #Ethics #FutureTrends #Investments

San Diego, here we come! We're so excited for the topics our panelists will be discussing tomorrow, September 18th. Whether you’re a large or small biotech company, early- or commercial-stage, we'll have something for you!   Will we see you at the InterContinental Hotel in San Diego tomorrow?? This is the last day to grab your ticket! Head to our website to see our full speaker lineup and register: https://lnkd.in/e9-QR5Rg

✨ Heading to the BioLife Summit? ✨ Stop by the Collaborative Clinical Research Consulting, Inc. table to discuss your clinical study needs and learn how we can support your projects from start to finish! Our team of seasoned professionals is ready to answer any questions and show how we can help you streamline your trials, manage operations, and deliver results on time and within budget. 🧪📋 Don’t miss the chance to explore our tailored clinical trial services and discover why we're the right partner for your success. 💡👩🔬 We can’t wait to meet you at the Summit! 😊👋 📍 Visit us at our booth and let’s talk about how we can take your trials to the next level! BioLife Summits

This week, Michael Howell, PhD, our CSO, will be speaking at the Southern California BioLife Summit!     Join us at this regional gathering of biotech, pharma and healthcare industry experts to engage in meetings and presentations about the newest breakthroughs, insights and trends in the field. Hope to see you there!